Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-β2 gene

Experimental Nephrology

Volumn 10, Issue 5-6, 2002, Pages 374-382

  Pietri, Laurence ^a   Bloch Faure, May ^a   Belair, Marie France ^a   Sanford, L Philip ^b   Doetschman, Tom ^b   Ménard, Joël ^a   Bruneval, Patrick ^a   Meneton, Pierre ^a,c  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c INSERM   (France)

Author keywords

Heterozygous deficient mice; Kidneys; Renin synthesis and secretion; Transforming growth factor 2

Indexed keywords

RENIN; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEHYDRATION; GENE FUNCTION; GENE MUTATION; HETEROZYGOSITY; HYDRATION; IN VIVO STUDY; JUXTAGLOMERULAR APPARATUS; MOUSE; MUTANT; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; WILD TYPE;

ANIMALS; ARTERIOLES; BODY WATER; DEHYDRATION; FETUS; GENE DELETION; GENOTYPE; HETEROZYGOTE; JUXTAGLOMERULAR APPARATUS; KIDNEY; MICE; MICE, INBRED C57BL; MUTATION; RENAL CIRCULATION; RENIN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; WATER DEPRIVATION;

EID: 0036966712     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065302     Document Type: Article

References (38)

1. Nicholls MG, Robertson JI: The renin-angiotensin system in the year 2000. J Hum Hypertens 2000;14:649-666.
2. Allikmets K, Parik T, Viigimaa M: The renin-angiotensin system in essential hypertension: Associations with cardiovascular risk. Blood Press 1999;8:70-78.
3. Farmer JA: Renin-angiotensin system and ASCVD. Curr Opin Cardiol 2000;15:141-150.
4. Rabelink TJ, Bakris GL: The renin-angiotensin system in diabetic nephropathy: The endothelial connection. Miner Electrolyte Metab 1998;24:381-388.
5. Inagami T: A memorial to Robert Tiegerstedt: The centennial of renin discovery. Hypertension 1998;32:953-957.
6. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180.
7. Smithies O: Theodore Cooper Memorial Lecture. A mouse view of hypertension. Hypertension 1997;30:1318-1324.
8. Lindop GB, Lever AF: Anatomy of the renin-angiotensin system in the normal and pathological kidney. Histopathology 1986;10:335-362.
9. Pratt RE, Carleton JE, Richie JP, Heusser C, Dzau VJ: Human renin biosynthesis and secretion in normal and ischemic kidneys. Proc Natl Acad Sci USA 1987;84:7837-7840.
10. Blair-West JR, Coghlan JP, Denton DA, Scoggins BA, Wintour M, Wright RD: The renin-angiotensin-aldosterone system in sodium depletion. Med J Aust 1967;ii:290-293.
11. Kurtz A, Wagner C: Cellular control of renin secretion. J Exp Biol 1999;202:219-225.
12. Gomez RA, Chevalier RL, Carey RM, Peach MJ: Molecular biology of the renal renin-angiotensin system. Kidney Int Suppl 1990;30:S18-S23.
13. Kurtz A, Scholz H, della Bruna R: Molecular mechanisms of renin release. J Cardiovasc Pharmacol 1990;16(suppl 4):S1-S7.
14. Shricker K, Holmer S, Kramer BK, Riegger GA, Kurtz A: The role of angiotensin II in the feedback control of renin gene expression. Pflügers Arch 1997;434:166-172.
15. Ichihara A, Suzuki H, Murakami M, Naitoh M, Matsumoto A, Saruta T: Interactions between angiotensin II and norepinephrine on renin release by juxtaglomerular cells. Eur J Endocrinol 1995;133:569-577.
16. 1A receptors and renin release in rat juxtaglomerular cells. Hypertension 1997;29:962-968.
17. Kurtz A, Wagner C: Role of nitric oxide in the control of renin secretion. Am J Physiol 1998;275:F849-F862.
18. Antonipillai I, Wang Y, Horton R: Tumor necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 1990;126:273-278.
19. Antonipillai I, Horton R: Paracrine regulation of the renin-aldosterone system. J Steroid Biochem Mol Biol 1993;45:27-31.
20. Roberts AB, Sporn MB: Transforming growth factor β. Adv Cancer Res 1988;51:107-145.
21. 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000;97:3479-3484.
22. Antonipillai I, Le TH, Soceneantu L, Horton R: Transforming growth factor-β is a renin secretagogue at picomolar concentrations. Am J Physiol 1993;265:F537-541.
23. 2 accumulation in the juxtaglomerular apparatus of mouse kidney. J Clin Invest 1991;88:2117-2122.
24. 2 and renin by potassium depletion. Kidney Int 1993;44:1006-1013.
25. 2. Contrib Nephrol. Basel, Karger, 1996, vol 118, pp 238-248.
26. 2 expression in the glomerular arteriole of the juxtaglomerular apparatus in a Bartter's-like syndrome. Hum Pathol 1999;30:992-995.
27. Liu A, Ballermann BJ: TGF-β type II receptor in rat renal vascular development: Localization to juxtaglomerular cells. Kidney Int 1998;53:716-725.
28. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips IJ, Newman J, Williams D, Galie N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC: BMPR2 Haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001;68:92-102.
29. 2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-β knock-out phenotypes. Development 1997;124:2659-2670.
30. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-1995.
31. Bruneval P, Fournier JG, Soubrier F, Belair MF, da Silva JL, Guettier C, Pinet F, Tardivel I, Corvol P, Bariety J, Camilleri JP: Detection and localization of renin messenger RNA in human pathologic tissues using in situ hybridization. Am J Pathol 1988;131:320-330.
32. Richer C, Bruneval P, Menard J, Giudicelli JF: Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Hypertension 1998;31:692-698.
33. Galen FX, Devaux C, Atlas S, Guyenne T, Menard J, Corvol P, Simon D, Cazaubon C, Richer P, Badouaille G, Richaud JP, Gros P, Pau B: New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin Invest 1984;74:723-735.
34. Menard J, Catt KJ: Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 1972;90:422-430.
35. Smithies O, Kim HS, Takahashi N, Edgell MH: Importance of quantitative genetic variations in the etiology of hypertension. Kidney Int 2000;58:2265-2280.
36. Kim HS, Maeda N, Oh GT, Fernandez LG, Gomez RA, Smithies O: Homeostasis in mice with genetically decreased angiotensinogen is primarily by an increased number of renin-producing cells. J Biol Chem 1999;274:14210-14217.
37. Nakamura N, Soubrier F, Menard J, Panthier JJ, Rougeon F, Corvol P: Non-proportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA. Hypertension 1985;7:855-859.
38. Ho SC, Izumi H, Cojocel C, Michelakis AM: Role of kidney and liver in degradation of circulating submaxillary renin in mice. J Lab Clin Med 1984;103:125-136.